| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 06/27/1996 | CA2206778A1 Peptides having immunomodulatory activity |
| 06/26/1996 | EP0718308A2 Peptide derivatives having binding activity to modified low density lipoprotein |
| 06/26/1996 | EP0717752A1 Therapeutic compounds |
| 06/26/1996 | EP0717750A1 Double-stranded peptide nucleic acids |
| 06/26/1996 | CN1125451A Biologically active vasopressin analogues |
| 06/26/1996 | CN1125400A Use of nona- and decapeptides in the preparation of a drug for the treatment of aids |
| 06/26/1996 | CN1125399A Immunogenic cancer proteins and peptides and method of use |
| 06/25/1996 | US5530096 Diagnosis and therapy of tumors, autoimmune diseases |
| 06/25/1996 | US5530095 Skin disorders, antitumor agents |
| 06/25/1996 | US5529919 Method of making endoglucanase I |
| 06/25/1996 | US5529915 Lyophilized polyethylene oxide modified protein and polypeptide complexes with cyclodextrin |
| 06/20/1996 | WO1996018653A1 Disulphide-cyclo-[h-cys-glu-gln-tyr-cys-oh], and its use in blood-clotting disorders |
| 06/20/1996 | WO1996018652A1 Hexapeptides possessing antitumor activity |
| 06/20/1996 | WO1996018645A1 Peptides and synthetic cell membranes |
| 06/20/1996 | WO1996018642A1 Amino acids for making betides and methods of screening and making betide libraries |
| 06/20/1996 | WO1996018408A1 Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides |
| 06/20/1996 | WO1996012809A3 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
| 06/20/1996 | DE4444893A1 Peptide und synthetische Zellmembranen Peptides and synthetic membranes |
| 06/20/1996 | CA2206258A1 Amino acids for making betides and methods of screening and making betide libraries |
| 06/19/1996 | EP0717048A1 Cyclic hexapeptides and their mixings, process to synthesize them and their use |
| 06/19/1996 | EP0716661A1 Pseudo- and non-peptide bradykinin receptor antagonists |
| 06/19/1996 | EP0535192B1 Novel dna gyrase inhibitors, process for their manufacture and pharmaceutical preparations containing same |
| 06/19/1996 | EP0527778B1 Improved process of purifying recombinant proteins and compounds useful in such process |
| 06/19/1996 | EP0516851B1 Physiologically active substance well capable of permeating biomembrane |
| 06/19/1996 | EP0489089B1 Therapeutic peptides |
| 06/19/1996 | CN1124964A Trifunctional antithrombin and antiplatelet peptides |
| 06/19/1996 | CN1124927A Analogs of peptide YY and uses thereof |
| 06/19/1996 | CN1124739A Vaccin peptide of blood fluke |
| 06/18/1996 | US5527882 Polypeptide having an amino acid replaced with N-benzylglycine |
| 06/18/1996 | US5527777 Peptide compounds, in particular LHRH-antagonists |
| 06/18/1996 | US5527681 Immobilized molecular synthesis of systematically substituted compounds |
| 06/18/1996 | US5527610 Comprising tetrapeptide or pentapeptide repeating units containing proline and glycine with optional alanine residues |
| 06/18/1996 | US5527537 Contains natural oils, 3-sn-phosphatidyl choline and/or phosphatidyl ethanolamine and water |
| 06/13/1996 | WO1996017942A1 Production of peptides using recombinant fusion protein constructs |
| 06/13/1996 | WO1996017937A2 PESTICIDAL COMPOSITION COMPRISING CryIF CHIMERIC AND CryIA(c) CHIMERIC BACILLUS THURINGIENSIS DELTA-ENDOTOXIN |
| 06/13/1996 | WO1996017862A1 Lhrh antagonists having lactam groups at the n-terminus |
| 06/13/1996 | WO1996017861A1 Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase |
| 06/13/1996 | WO1996017619A1 Compounds and methods for controlling reproduction in fish |
| 06/13/1996 | WO1996017617A1 Neuromedin b receptor antagonists |
| 06/13/1996 | WO1994026906A3 Cloned dna encoding a udp-galnac:polypeptide,n-acetylgalactos aminyltransferase |
| 06/13/1996 | CA2206848A1 Production of peptides using recombinant fusion protein constructs |
| 06/13/1996 | CA2205663A1 Neuromedin b receptor antagonists |
| 06/13/1996 | CA2204144A1 Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase |
| 06/12/1996 | EP0590044A4 Composition and treatment with biologically active peptides having c-terminal substitutions |
| 06/12/1996 | EP0537318B1 New non-hygroscopic mono-ammonium salts |
| 06/12/1996 | EP0293471B1 Primary biliary cirrhosis autoantigen |
| 06/12/1996 | CN1124455A Therapeutic uses of bactericidal/permeability increasing protein products |
| 06/11/1996 | US5525717 Support-bound nucletide probe for neisseria gonorrhoeae |
| 06/11/1996 | US5525591 Human or veterinary medicine |
| 06/11/1996 | US5525590 Immunosuppressants, antiinflammatory and antiparasitic |
| 06/07/1996 | WO1996017869A2 Interleukin-6 (il-6) antagonists |
| 06/07/1996 | CA2177837A1 Interleukin-6 (il-6) antagonists |
| 06/06/1996 | WO1996016983A1 Cooperative combinations of ligands contained within a matrix |
| 06/06/1996 | CA2206175A1 Cooperative combinations of ligands contained within a matrix |
| 06/05/1996 | EP0714912A2 GMP-140 derived lektin-like domain peptides and their ligands |
| 06/05/1996 | EP0714911A2 Somastotatin analogs containing chelating groups and their radiolabeled compositions |
| 06/05/1996 | EP0714910A1 Use of a decapeptide with a benzodiazepine activity for the preparation of medicaments and dietary supplements |
| 06/05/1996 | EP0714909A1 Composition for prophylaxis or treatment of pulmonary circulatory diseases |
| 06/05/1996 | EP0714665A2 Osteogenic devices |
| 06/05/1996 | EP0714404A1 Anti-inflammatory peptides |
| 06/02/1996 | CA2164165A1 Composition for prophlaxis or treatment of pulmonary circulatory diseases |
| 05/30/1996 | WO1996016172A2 Modulators of anchoring protein function |
| 05/30/1996 | WO1996016169A1 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof |
| 05/30/1996 | WO1996016081A1 Bradykinin antagonist peptides containing indane-substituted amino acids |
| 05/30/1996 | WO1996015768A1 Oral compositions |
| 05/30/1996 | CA2204438A1 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof |
| 05/30/1996 | CA2181826A1 Modulators of anchoring protein function |
| 05/29/1996 | EP0713495A1 Methods of enhancing bioactivity of chemokines |
| 05/28/1996 | US5521284 Human cancer inhibitory pentapeptide amides and esters |
| 05/28/1996 | US5521158 Pseudopeptide bradykinin receptor antagonists |
| 05/28/1996 | US5521156 Cyclic neurokinin A antagonists |
| 05/28/1996 | US5521155 Antibiotic active against grampositive bacteria |
| 05/23/1996 | WO1996015258A1 A scintillation proximity assay for n-acetylgalactosaminyltransferase activity |
| 05/23/1996 | WO1996015148A2 Low molecular weight peptidomimetic growth hormone secretagogues |
| 05/23/1996 | WO1996015142A1 Process for performing retro-aldol reaction |
| 05/23/1996 | WO1996015141A1 Cholesteryl ester transfer protein inhibitor peptides and prophylactic and therapeutic anti-arteriosclerosis agents |
| 05/23/1996 | WO1996014858A1 Use of angiotensin ii fragments and analogs thereof in tissue repair |
| 05/23/1996 | WO1996014856A1 Cancer inhibitory peptides |
| 05/23/1996 | CA2205369A1 Process for performing retro-aldol reaction |
| 05/23/1996 | CA2203375A1 Low molecular weight peptidomimetic growth hormone secretagogues |
| 05/21/1996 | US5519117 Polypeptide sequences as anticarcinogenic agents |
| 05/21/1996 | US5519116 Peptides representing permutations of the mastoparan sequence |
| 05/21/1996 | US5519115 Reverse antimicrobial peptides |
| 05/21/1996 | US5519004 Elastomeric polypeptide matrices for preventing adhesion of biological materials |
| 05/21/1996 | US5518888 Imaging metastasized colorectal cancer, toxtin peptides less than 25 units |
| 05/17/1996 | WO1996014333A1 Peptides for anti-allergy treatment |
| 05/17/1996 | CA2204256A1 Peptides for anti-allergy treatment |
| 05/16/1996 | CA2135813A1 Treatment of obesity |
| 05/15/1996 | EP0711550A1 Cyclosporin-containing soft capsule compositions |
| 05/15/1996 | EP0711415A1 Immunoassay for detecting collagen or collagen fragments |
| 05/15/1996 | EP0711307A1 Peptides for neutralizing the toxicity of lipid a |
| 05/15/1996 | EP0711305A1 Protegrins |
| 05/15/1996 | EP0711173A1 Isolated peptides which form complexes with mhc molecule hla-c-clone 10 and uses thereof |
| 05/15/1996 | EP0462182B1 Matrix metalloproteinase peptides: role in diagnosis and therapy |
| 05/15/1996 | EP0400076B1 A synthetic antigen evoking anti-hiv response |
| 05/15/1996 | CN1122613A Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainable |
| 05/15/1996 | CN1122602A Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 05/15/1996 | CN1122577A Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders |
| 05/14/1996 | US5516887 Luteinizing hormone releasing hormone antagonist peptides |
| 05/14/1996 | US5516759 LHRH antagonists having lactam groups at the N-terminus |